e-learning
resources
Virtual 2021
06.09.2021
Pharmacology of lung immune responses: which pathways to target!
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The yin and yang of immunosuppression with inhaled corticosteroids in asthma and COPD
P. Barnes (London, United Kingdom)
Source:
Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!
Session:
Pharmacology of lung immune responses: which pathways to target!
Session type:
Symposium
Number:
2716
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Barnes (London, United Kingdom). The yin and yang of immunosuppression with inhaled corticosteroids in asthma and COPD. Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003
Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004
Inhaled steroids in exacerbations of COPD
Source: Eur Respir J 2007; 30: 398
Year: 2007
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010
Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab
Source: Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018
Year: 2018
The role of inhaled corticosteroids in the management of acute asthma
Source: Eur Respir J 2007; 30: 1035-1037
Year: 2007
Children with mild asthma: do they benefit from inhaled corticosteroids?
Source: Eur Respir J 2002; 20: 1470-1475
Year: 2002
Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations
Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Year: 2018
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Inhaled steroids and COPD
Source: Eur Respir J 2008; 32: 523-524
Year: 2008
Pharmacogenetics of inhaled corticosteroid response in adults with asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
ERS guideline on withdrawal of inhaled corticosteroids in COPD
Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD
Year: 2021
Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Year: 2017
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016
Year: 2017
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept